We are live on
!
Find out more
BRCM
Bright Rock Capital Management Portfolio holdings
AUM
$499M
1-Year Est. Return
8.36%
This Fund
S&P 500
This Quarter
Est. Return
+2.69%
1 Year Est. Return
+8.36%
3 Year Est. Return
+41.76%
5 Year Est. Return
+64.28%
10 Year Est. Return
+252.44%
AUM
$339M
AUM Growth
+$4.33M
(+1.3%)
Cap. Flow
-$2.28M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
23.61%
Holding
90
New
2
Increased
5
Reduced
12
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$5.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$4.7M |
| 3 |
Zoetis
ZTS
|
+$4.43M |
| 4 |
Oceaneering
OII
|
+$1.4M |
| 5 |
SLB Ltd
SLB
|
+$860K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$7.81M |
| 2 |
NOV
NOV
|
+$5.97M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.28M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$936K |
| 5 |
Cognizant
CTSH
|
+$635K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.09% |
| 2 | Communication Services | 11.01% |
| 3 | Industrials | 9.23% |
| 4 | Financials | 9.22% |
| 5 | Energy | 8.19% |
Similar funds
HCI
KCL
PPC
AGP
MIP
H2CM
HIC
SWM
Bright Rock Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Bright Rock Capital Management held 90 positions worth $339M, up 1.3% from $335M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 4.4%. Bright Rock Capital Management opened 2 new positions and exited 2, leaving the 90-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 11% a quarter earlier, followed by Communication Services and Industrials.
- Bright Rock Capital Management's largest Q2 2017 buy was Zoetis: 75,000 shares worth $4.68M.
- Bright Rock Capital Management added most to Chevron in Q2 2017, an estimated $5.3M increase.
- Bright Rock Capital Management's biggest Q2 2017 reduction was Johnson & Johnson, cutting an estimated $1.28M.
- Bright Rock Capital Management fully exited Gilead Sciences in Q2 2017, selling an estimated $7.81M.
- Bright Rock Capital Management's ten largest holdings make up 24% of its $339M portfolio in Q2 2017.
- Bright Rock Capital Management opened 2 new positions and closed 2 in Q2 2017.
- Bright Rock Capital Management's portfolio value rose 1.3% quarter-over-quarter to $339M.
Based on Bright Rock Capital Management's 13F filing for Q2 2017, filed 1 Aug 2017.